Nicotinic acid
|
Basic information |
| Metabolite name | Nicotinic acid |
 | HMDB0001488 |
 |
C00253 |
 |
938 |
| Synonyms | Niacin; |
| No. of studies | 22 |
|
Basic information |
| Metabolite name | Nicotinic acid |
| HMDB0001488 |
|
C00253 |
|
938 |
| Synonyms | Niacin; |
| No. of studies | 22 |
|
Relationship between Nicotinic acid and depression (count: 22) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M036 | Type1 | MDD group vs. control group | Urine | Human | Up |
| Study M042 | Type3 | fluoxetine group vs. control group | Plasma | Rhesus monkey | Up |
| Study M043 | Type1 | chronic hepatitis B patients with MDD group vs. without MDD group | Urine | Human | Down |
| Study M089 | Type3 | fluoxetine vs. control group | Fibroblast | Rhesus monkey | Up |
| Study M097 | Type1 | depressed men group vs. control men group | Urine | Human | Up |
| Study M097 | Type1 | depressed women group vs. control women group | Urine | Human | Up |
| Study M102 | Type1 | moderate MDD group vs. control group | Urine | Human | Up |
| Study M102 | Type1 | severe MDD group vs. control group | Urine | Human | Up |
| Study M1090 | Type3 | hyperbaric oxygen treatment group vs. control group | Plasma | BALb/c mouse | Up |
| Study M1097 | Type1 | placebo-treated depression group vs. control group | Faece | Human | Down |
| Study M117 | Type1 | CVS group vs. control group | Faece | Wistar rat | Up |
| Study M480 | Type1 | sleep deprivation group vs. control group | Urine | Wistar rat | Down |
| Study M512 | Type1 | CUMS group vs. control group | Urine | Goto-Kakizaki rat | Up |
| Study M556 | Type1 | sleep deprivation group vs. control group | Urine | Wistar rat | Down |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Serum | C57BL/6 J mouse | Down |
| Study M651 | Type1 | LPS group vs. control group | Plasma | C57BL/6 mouse | Down |
| Study M651 | Type2 | LPS + fish oil group vs. LPS group | Plasma | C57BL/6 mouse | Up |
| Study M677 | Type1 | CVS group vs. control group | Faece | Wistar rat | Up |
| Study M677 | Type2 | CVS + fluoxetine group vs. CVS group | Faece | Wistar rat | Down |
| Study M677 | Type2 | CVS + Chaihu-Shu-Gan-San group vs. CVS group | Faece | Wistar rat | Down |
| Study M712 | Type1 | depression group vs. control group | Amygdala | Cynomolgus monkey | Down |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Up |
| Study M806 | Type2 | corticosterone + taxifolin spina group vs. corticosterone group | Urine | C57BL/6 mouse | Down |
| Study M823 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M839 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M912 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M940 | Type1 | CUMS group vs. control group | Cerebral cortex | Sprague-Dawley rat | Up |
| Study M940 | Type2 | CUMS + Chaihu-Baishao herb pair group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Down |
| Study M940 | Type2 | CUMS + Chaihu group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Down |